logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
05/11/2025
Wecai's second-quarter operating profit was 13.67 billion yen, estimated at 17.08 billion yen.
Latest
2 m ago
Sichuan Gold established a mining company in Xinjiang.
2 m ago
Kem One New Materials: The company's PEKK products have been applied in various fields such as additive manufacturing.
3 m ago
Bright Ocean Pharmaceutical has obtained the exclusive distribution rights of the albumin product Ambomei in mainland China.
3 m ago
Danish pharmaceutical giant Novo Nordisk has lowered its performance expectations for the fourth time this year, citing lower-than-expected sales of its star drugs, Wegovy and Ozempic. The company said on Wednesday that, based on fixed exchange rates, sales for the year are expected to increase by at most 11% and operating profit by at most 7%, lower than the previous expectations of 14% and 10%, respectively. While Novo Nordisk had initially led the weight loss drug market with Ozempic and Wegovy, the company's fate began to shift last year when an experimental injectable drug failed to deliver on promised weight loss effects in clinical trials. Novo Nordisk is now pinning hopes on an oral version of Wegovy to revive growth. Its stock price has dropped by about half this year.
4 m ago
The US government shutdown impacts the US stock IPO market: SEC reviews are stalled, end-of-year listing pushes are blocked.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.